CL vs KMB
Colgate-Palmolive and Kimberly-Clark, both Consumer Defensive
Colgate-Palmolive is the larger company at $72B against $34B. On trailing earnings KMB is the cheaper of the two at a P/E of 16.6 against 34.9, a gap that is only a bargain if the two are growing at similar rates. Over the past year CL returned +10% against -19% for KMB. The RyuScore puts CL ahead, 74 against 66 out of 100.
| Figure | CL | KMB |
|---|---|---|
| Last close | $88.27 | $97.60 |
| Market cap | $72B | $34B |
| Trailing P/Elower is cheaper for the same earnings, not automatically better | 34.9 | 16.6 |
| Dividend yield | 2.4% | 5.2% |
| 1-year return | +10% | -19% |
| 5-year return | +28% | -15% |
| RyuScoresector-relative, 1–10 | 74/100 | 66/100 |
Figures from SEC filings and end-of-day closes. Highlighting marks the higher or lower number, which is not the same as the better investment, a low P/E can be a warning and a high one can be deserved.
Colgate-Palmolive
Revenue of $5.4B in Q2 2026, net income $693M. Its largest reported line is Latin America, 33% of the disclosed total.
Kimberly-Clark
Revenue of $4.2B in Q2 2026, net income $345M. Its largest reported line is Babyandchildcareproducts, 42% of the disclosed total.
Open these two in the interactive comparison to add more names, change the period or see the correlation.